International Biotechnology (IBT) Stock Chart & Stock Price History GBX 684 +10.00 (+1.48%) (As of 12/20/2024 11:48 AM ET) Add Compare Share Share Chart Stock AnalysisChartCompetitorsDividendHeadlinesInsider Trades International Biotechnology Stock Price Performance 5 Day Performance-2.01%1 Month Performance-0.29%3 Month Performance-1.44%6 Month Performance+5.56%Year-To-Date Performance+6.54%1 Year Performance+11.76% Receive IBT Stock News and Ratings via EmailSign-up to receive the latest news and ratings for International Biotechnology and its competitors with MarketBeat's FREE daily newsletter. Email Address We recommended Palantir in 2021, now we’re recommending this... (Ad)My research indicates there is only one investment that can meet AI's unprecedented demand for energy.Click to get the name and ticker symbol IBT Stock Chart for Sunday, December, 22, 2024 IBT Chart by TradingView International Biotechnology Stock Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization12/20/2024GBX 674GBX 684+1.48%GBX 686GBX 66724,429 shs£252.81 million12/19/2024GBX 708GBX 674-4.80%GBX 694GBX 66648,480 shs£249.11 million12/18/2024GBX 698GBX 708+1.43%GBX 708GBX 696.4360,390 shs£261.68 million12/17/2024GBX 716GBX 698-2.51%GBX 715.86GBX 69858,431 shs£257.98 million12/16/2024GBX 706GBX 716+1.42%GBX 716GBX 69667,050 shs£264.63 million12/13/2024GBX 714GBX 706-1.12%GBX 718GBX 70486,972 shs£260.94 million Get the Latest News and Ratings for IBT and Related StocksEnter your email address below to receive the latest news and analysts' ratings for International Biotechnology and its competitors with MarketBeat's FREE daily newsletter. 12/12/2024GBX 712GBX 714+0.28%GBX 718GBX 70267,518 shs£263.89 million12/11/2024GBX 704GBX 712+1.14%GBX 716GBX 70483,443 shs£263.16 million12/10/2024GBX 704GBX 704GBX 710GBX 694138,866 shs£260.20 million12/09/2024N/AGBX 704GBX 710GBX 702.2626,854 shs£260.20 million12/06/2024GBX 698GBX 700+0.29%GBX 704.97GBX 695.4651,088 shs£258.72 million12/05/2024GBX 698GBX 698GBX 708GBX 69430,616 shs£257.98 million12/04/2024GBX 710GBX 698-1.69%GBX 714GBX 69840,660 shs£257.98 million12/03/2024GBX 710GBX 710GBX 720GBX 70484,252 shs£262.42 million12/02/2024GBX 704GBX 710+0.85%GBX 712GBX 70296,795 shs£262.42 million11/29/2024GBX 700GBX 703.65+0.52%GBX 708GBX 69458,415 shs£260.07 million11/28/2024GBX 698GBX 700+0.29%GBX 708.14GBX 690.52121,663 shs£258.72 million11/27/2024GBX 694GBX 698+0.58%GBX 702GBX 69447,838 shs£257.98 million11/26/2024GBX 694GBX 694GBX 704GBX 69089,613 shs£256.50 million11/25/2024N/AGBX 694GBX 701.92GBX 689.12257,752 shs£256.50 million11/22/2024GBX 678GBX 686+1.18%GBX 686.46GBX 676138,466 shs£253.55 million11/21/2024GBX 674GBX 678+0.59%GBX 680GBX 667.12116,841 shs£250.59 million Related Companies Fidelity China Special Stock Chart Capital Gearing Stock Chart Fidelity Investment Trust - Fidelity Special Values Stock Chart TR Property Investment Trust Stock Chart Impax Environmental Markets Stock Chart Ruffer Investment Stock Chart BlackRock World Mining Trust Stock Chart Ninety One Group Stock Chart Scottish American Investment Stock Chart Baillie Gifford US Growth Stock Chart Receive IBT Stock News and Ratings via EmailSign-up to receive the latest news and ratings for International Biotechnology and its competitors with MarketBeat's FREE daily newsletter. This page (LON:IBT) was last updated on 12/22/2024 by MarketBeat.com Staff From Our PartnersWARNING: “Buffett Indicator” flashing for first time in 50 yearsWarren Buffett has sold a staggering $97 billion worth of stocks this year... But why? Our research indi...Behind the Markets | SponsoredRare "crisis signal" triggers for third time in U.S. marketA rare pattern has just repeated for the third time in U.S. history. The last two times this happened, the...Stansberry Research | SponsoredCould This Tiny Device Help You Make an Extra $30k a Year?I believe it’s going to power Elon Musk’s next AI revolution… A revolution he believes will be worth more t...Brownstone Research | SponsoredHOTTEST TRADER IN AMERICA 🔥🔥🔥Ready for a rocket ride this weekend? After alerting his readers to a tiny $2 stock called Bright Minds Bio...Timothy Sykes | SponsoredBuffett's Oil Bet + This 22% Dividend PlayWarren Buffett has been quietly amassing a massive position in oil stocks. But while Buffett's picks (Occid...Investors Alley | SponsoredBuy this coin BEFORE Inauguration Day …Mark my words … Bitcoin is going to $100,000. BEFORE Trump is inaugurated. And I think it could reach $1...Weiss Ratings | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowAltcoin season moves fast, and those who hesitate are left behind. The window is closing.Crypto Swap Profits | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding International Biotechnology Please log in to your account or sign up in order to add this asset to your watchlist. Share International Biotechnology With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.